Biotech ETF Rises 17% in a Month Without NVIDIA
A biotech ETF posts a 17% gain in the trailing month even as NVIDIA weakens, underscoring a sector rotation that chal...
Identify dividend ETFs with the cheapest expense ratios without sacrificing reliability. This guide helps distinguish leaders in low-cost access.
27,552 articlesA biotech ETF posts a 17% gain in the trailing month even as NVIDIA weakens, underscoring a sector rotation that chal...
A fresh analysis shows WisdomTree's WCLD underperforms due to equal-weight rebalancing, turning a $10,000 stake into ...
Solana's SOL token flashed a buy signal, signaling a potential rally. Analysts see targets near $96 and $120 if momen...
As U.S. bond markets stabilize in 2026, investors compare BND and AGG for broad fixed-income exposure. Both funds tra...
In 2026, XLK’s cap-driven approach has quietly outpaced FTEC. Concentration limits are redirecting capital toward sem...
Two oil giants linked to Guyana just posted a staggering combined profit. Here’s what investors need to know about pr...
Grayscale argues that saylor’s strategy $1.5bb cashflow is being squeezed by a growing load of preferred-stock obliga...
Dogecoin slides toward the $0.09 mark as on-chain activity shows holders scooping up DOGE while institutional flows s...
Roundhill's DRAM ETF, with a 49% Korea weighting, has surged but faces overnight gaps as half its holdings trade when...
As AI demand drives 24/7 data-center power, investors pivot from solar bets to nuclear plays. The nuclear fund is del...
Investors are testing a new approach to fund life’s milestones—without tapping the core retirement nest egg. The cele...
Investors eyeing $12,000 a month in passive income are rethinking portfolio size as yields rise. This piece lays out ...